The Food and Drug Administration, facing increased criticism of its regulatory process for gene-edited animals, is mounting a new effort to defend its policies to farmers, researchers and developers, but the industry is backing the Agriculture Department's push to take over some of FDA's oversight role.
To view this article, please
login. If you are not a current subscriber, you may sign up for a trial or view other subscription options
here.